posted by:
Wendy W. Blackburn
at 9:57 PM
August 24, 2010
I've been receiving a few questions from clients and contacts lately on which conferences are the best to attend. I've been to a few of them, and they all have their pros and cons. If you're planning your autumn 2010 lineup of pharma marketing-related conferences like I am, I hope you find ...
posted by:
Wendy W. Blackburn
at 5:33 PM
August 17, 2010
It's back-to-school time for many of the kiddos, so an education theme seemed relevant for today's post.
It’s true, lots has been said, blogged, and tweeted about the DDMAC letter to Novartis regarding its social sharing tool on a branded website. Blogger Richard Meyer even criticized the buzz, telling everyone ...
posted by:
Wendy W. Blackburn
at 7:16 PM
August 9, 2010
Intouch Solutions' Official POV
For those of you following the commentary on FDA's letter to Novartis regarding social sharing widgets (can we call it WidgetGate for fun?!), Intouch Solutions has some new information and recommendations to share with you.
Yesterday I posted a recap, analysis, and collection of musings ...
posted by:
Wendy W. Blackburn
at 9:14 PM
August 8, 2010
Introduction
On July 29, 2010, the Division of Drug Marketing, Advertising, and Communications (DDMAC) of the U.S. Food and Drug Administration (FDA) issued a notice of violation letter to Novartis indicating that communications created by a social media sharing widget on several Tasigna websites violated the Federal Food, Drug, and ...
posted by:
Wendy W. Blackburn
at 3:49 PM
August 4, 2010
Pharma – as you know – is full of silos. Marketing, public relations, sales, and customer service all inherently have the same end goals, yet operate in extremely disparate internal functions. Some companies are better than others, but all seem to have their special struggles. Unfortunately, that can translate to ...